Complementary antioxidant medicine in COVID-19 management and the place of haematology evaluation: Brief critical and scoping review-based commentary

Research output: Contribution to journalArticlepeer-review

8 Downloads (Pure)

Abstract

The purpose of this commentary is to articulate herbal remedies for COVID-19 among geriatric care clients and also the role of haematology evaluation in non symptomatic individuals. Two review methods were employed to develop this narrative commentary. First, data in social media article and refereed research journals critically reviewed. In particular, knowledge about treatment options are used to substantiate potential implications for geriatric care and haematological tests in asymptomatic patients. This commentary touched on (1) alternatives to vaccination, (2) COVID19 treatment roadmap, (3) difference in response of adults and children, and (4) geriatric and asymptomatic individuals’ need for haematology. Second, a brief scoping review was done to discuss the question “if medicines we already have are good enough to buy patients more time”. The highlight is antioxidant naturopathy for COVID-19 management. What has yet to be really authenticated, which constitutes the contribution of this article, is that immunocompromised status of geriatric care clients underlies unavoidable burden of frailty. This contraindicates at least 25% of COVID-19 vaccines being researched; and warrants caution in consideration of anti-inflammatories that constitute 52% of drugs currently being developed. The implication is that geriatric care could benefit more for alternative traditional medicine such as herbs based on their antioxidant and immunomodulation properties. Further, routine haematology vis-à-vis full blood count is indicated also in asymptomatic individuals.
Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalHematology & Medical Oncology
Volume5
DOIs
Publication statusPublished - 25 May 2020

Fingerprint

Dive into the research topics of 'Complementary antioxidant medicine in COVID-19 management and the place of haematology evaluation: Brief critical and scoping review-based commentary'. Together they form a unique fingerprint.

Cite this